FdaApplication
BLA 761166
Identifiers
- fda_app_no: BLA761166
Properties
| Property | Value |
|---|---|
| applicant_name | PharmaEssentia Corporation |
| application_type | BLA |
| approval_date | 2021-11-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BESREMI | ROPEGINTERFERON ALFA-2B-NJFT | 500MCG/ML | Injection |
| BESREMI | — | 500MCG/0.5ML | Injection |
2 products